Linking Gut Microbiota, Oral Microbiota, and Serum Metabolites in Insomnia Disorder: A Preliminary Study
Nature and Science of Sleep · 2024-12 · Volume 16 · 1959-1972
DOI: 10.2147/nss.s472675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature and Science of Sleep, 2024-12. Verfasst von Weifeng Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong, 523000, People…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Schlaf
Abstract (Originalsprache)
Purpose
Despite recent findings suggesting an altered gut microbiota in those suffering from insomnia disorder (ID), research into the gut microbiota, oral microbiota, serum metabolites, and their interactions in patients with ID is sparse. Patients and Methods: We collected a total of 114 fecal samples, 133 oral cavity samples and 20 serum samples to characterize the gut microbiota, oral microbiota and serum metabolites in a cohort of 76 ID patients (IDs) and 59 well-matched healthy controls (HCs). We assessed the microbiota as potentially biomarkers for ID for ID by 16S rDNA sequencing and elucidated the interactions involving gut microbiota, oral microbiota and serum metabolites in ID in conjunction with untargeted metabolomics.
Results
Gut and oral microbiota of IDs were dysbiotic. Gut and oral microbial biomarkers could be used to differentiate IDs from HCs. Eleven significantly altered serum metabolites, including adenosine, phenol, and phenol sulfate, differed significantly between groups. In multi-omics analyses, adenosine showed a positive correlation with genus_Lachnospira (p=0.029) and total sleep time (p=0.016). Additionally, phenol and phenol sulphate had a negative correlation with genus_Coprococcus (p=0.0059; p=0.0059) and a positive correlation with Pittsburgh Sleep Quality Index (p=0.006; p=0.006) and Insomnia Severity Index (p=0.021; p=0.021).
Conclusion
Microbiota and serum metabolite changes in IDs are strongly correlated with clinical parameters, implying mechanistic links between altered bacteria, serum metabolites and ID. This study offers novel perspective into the interaction among gut microbiota, oral microbiota, and serum metabolites for ID.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong, 523000, People's Republic of China.
- Department of Psychiatry, Sleep Medicine Center, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, 510632, People's Republic of China.
- Sleep Medicine Center, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510120, People's Republic of China.
- Department of Pathology, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong, 523000, People's Republic of China.
- Department of Psychology, The Third People's Hospital of Zhaoqing, Zhaoqing, Guangdong Province, 526060, People's Republic of China.
Zitieren
APA
Lin, W., Yang, Y., Zhu, Y., Pan, R., Liu, C., & Pan, J. (2024). Linking Gut Microbiota, Oral Microbiota, and Serum Metabolites in Insomnia Disorder: A Preliminary Study. Nature and Science of Sleep, Volume 16, 1959-1972. https://doi.org/10.2147/nss.s472675
Vancouver
Lin W, Yang Y, Zhu Y, Pan R, Liu C, Pan J. Linking Gut Microbiota, Oral Microbiota, and Serum Metabolites in Insomnia Disorder: A Preliminary Study. Nature and Science of Sleep. 2024;Volume 16:1959-1972. doi:10.2147/nss.s472675
BibTeX
@article{Lin2024,
author = {Lin, Weifeng and Yang, Yifan and Zhu, Yurong and Pan, Rong and Liu, Chaonan and Pan, Jiyang},
title = {Linking Gut Microbiota, Oral Microbiota, and Serum Metabolites in Insomnia Disorder: A Preliminary Study},
journal = {Nature and Science of Sleep},
year = {2024},
volume = {Volume 16},
pages = {1959--1972},
doi = {10.2147/nss.s472675}
}
EUVIMED